Global Percutaneous Left Atrial Appendage Closure Device Market Growth 2022-2028

Publication Month: Dec 2022 | No. of Pages: 105 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

The global market for Percutaneous Left Atrial Appendage Closure Device is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Percutaneous Left Atrial Appendage Closure Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Percutaneous Left Atrial Appendage Closure Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Percutaneous Left Atrial Appendage Closure Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Percutaneous Left Atrial Appendage Closure Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Percutaneous Left Atrial Appendage Closure Device players cover Abbott Laboratories, AtriCure, Boston Scientific Corporation, Johnson and Johnson and Lifetech Scientific Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Percutaneous Left Atrial Appendage Closure Device market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Percutaneous Left Atrial Appendage Closure Device market, with both quantitative and qualitative data, to help readers understand how the Percutaneous Left Atrial Appendage Closure Device market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Percutaneous Left Atrial Appendage Closure Device market and forecasts the market size by Type (Endocardial LAA Closure Devices and Epicardial LAA Closure Devices,), by Application (Hospitals, Ambulatory Surgery Centres and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Endocardial LAA Closure Devices
Epicardial LAA Closure Devices
Segmentation by application
Hospitals
Ambulatory Surgery Centres
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott Laboratories
AtriCure
Boston Scientific Corporation
Johnson and Johnson
Lifetech Scientific Corporation
Occlutech GmbH
Biosense Webster Inc
SentreHeart Inc.
MEDX Xelerator LP
Cardia Inc
Chapter Introduction
Chapter 1: Scope of Percutaneous Left Atrial Appendage Closure Device, Research Methodology, etc.
Chapter 2: Executive Summary, global Percutaneous Left Atrial Appendage Closure Device market size (sales and revenue) and CAGR, Percutaneous Left Atrial Appendage Closure Device market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Percutaneous Left Atrial Appendage Closure Device sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Percutaneous Left Atrial Appendage Closure Device sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Percutaneous Left Atrial Appendage Closure Device market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Abbott Laboratories, AtriCure, Boston Scientific Corporation, Johnson and Johnson, Lifetech Scientific Corporation, Occlutech GmbH, Biosense Webster Inc, SentreHeart Inc. and MEDX Xelerator LP, etc.
Chapter 14: Research Findings and Conclusion

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Percutaneous Left Atrial Appendage Closure Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Percutaneous Left Atrial Appendage Closure Device by Country/Region, 2017, 2022 & 2028
2.2 Percutaneous Left Atrial Appendage Closure Device Segment by Type
2.2.1 Endocardial LAA Closure Devices
2.2.2 Epicardial LAA Closure Devices
2.3 Percutaneous Left Atrial Appendage Closure Device Sales by Type
2.3.1 Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2017-2022)
2.3.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Type (2017-2022)
2.4 Percutaneous Left Atrial Appendage Closure Device Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgery Centres
2.4.3 Others
2.5 Percutaneous Left Atrial Appendage Closure Device Sales by Application
2.5.1 Global Percutaneous Left Atrial Appendage Closure Device Sale Market Share by Application (2017-2022)
2.5.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Application (2017-2022)
3 Global Percutaneous Left Atrial Appendage Closure Device by Company
3.1 Global Percutaneous Left Atrial Appendage Closure Device Breakdown Data by Company
3.1.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales by Company (2020-2022)
3.1.2 Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Company (2020-2022)
3.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue by Company (2020-2022)
3.2.1 Global Percutaneous Left Atrial Appendage Closure Device Revenue by Company (2020-2022)
3.2.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Company (2020-2022)
3.3 Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Company
3.4 Key Manufacturers Percutaneous Left Atrial Appendage Closure Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Percutaneous Left Atrial Appendage Closure Device Product Location Distribution
3.4.2 Players Percutaneous Left Atrial Appendage Closure Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Percutaneous Left Atrial Appendage Closure Device by Geographic Region
4.1 World Historic Percutaneous Left Atrial Appendage Closure Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue by Geographic Region
4.2 World Historic Percutaneous Left Atrial Appendage Closure Device Market Size by Country/Region (2017-2022)
4.2.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue by Country/Region
4.3 Americas Percutaneous Left Atrial Appendage Closure Device Sales Growth
4.4 APAC Percutaneous Left Atrial Appendage Closure Device Sales Growth
4.5 Europe Percutaneous Left Atrial Appendage Closure Device Sales Growth
4.6 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Growth
5 Americas
5.1 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Country
5.1.1 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Country (2017-2022)
5.1.2 Americas Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2017-2022)
5.2 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Type
5.3 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Region
6.1.1 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Region (2017-2022)
6.1.2 APAC Percutaneous Left Atrial Appendage Closure Device Revenue by Region (2017-2022)
6.2 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Type
6.3 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Percutaneous Left Atrial Appendage Closure Device by Country
7.1.1 Europe Percutaneous Left Atrial Appendage Closure Device Sales by Country (2017-2022)
7.1.2 Europe Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2017-2022)
7.2 Europe Percutaneous Left Atrial Appendage Closure Device Sales by Type
7.3 Europe Percutaneous Left Atrial Appendage Closure Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device by Country
8.1.1 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Type
8.3 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Percutaneous Left Atrial Appendage Closure Device
10.3 Manufacturing Process Analysis of Percutaneous Left Atrial Appendage Closure Device
10.4 Industry Chain Structure of Percutaneous Left Atrial Appendage Closure Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Percutaneous Left Atrial Appendage Closure Device Distributors
11.3 Percutaneous Left Atrial Appendage Closure Device Customer
12 World Forecast Review for Percutaneous Left Atrial Appendage Closure Device by Geographic Region
12.1 Global Percutaneous Left Atrial Appendage Closure Device Market Size Forecast by Region
12.1.1 Global Percutaneous Left Atrial Appendage Closure Device Forecast by Region (2023-2028)
12.1.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Percutaneous Left Atrial Appendage Closure Device Forecast by Type
12.7 Global Percutaneous Left Atrial Appendage Closure Device Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Product Offered
13.1.3 Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 AtriCure
13.2.1 AtriCure Company Information
13.2.2 AtriCure Percutaneous Left Atrial Appendage Closure Device Product Offered
13.2.3 AtriCure Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AtriCure Main Business Overview
13.2.5 AtriCure Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Offered
13.3.3 Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 Johnson and Johnson
13.4.1 Johnson and Johnson Company Information
13.4.2 Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Product Offered
13.4.3 Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson and Johnson Main Business Overview
13.4.5 Johnson and Johnson Latest Developments
13.5 Lifetech Scientific Corporation
13.5.1 Lifetech Scientific Corporation Company Information
13.5.2 Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Offered
13.5.3 Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Lifetech Scientific Corporation Main Business Overview
13.5.5 Lifetech Scientific Corporation Latest Developments
13.6 Occlutech GmbH
13.6.1 Occlutech GmbH Company Information
13.6.2 Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Product Offered
13.6.3 Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Occlutech GmbH Main Business Overview
13.6.5 Occlutech GmbH Latest Developments
13.7 Biosense Webster Inc
13.7.1 Biosense Webster Inc Company Information
13.7.2 Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Product Offered
13.7.3 Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Biosense Webster Inc Main Business Overview
13.7.5 Biosense Webster Inc Latest Developments
13.8 SentreHeart Inc.
13.8.1 SentreHeart Inc. Company Information
13.8.2 SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Product Offered
13.8.3 SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 SentreHeart Inc. Main Business Overview
13.8.5 SentreHeart Inc. Latest Developments
13.9 MEDX Xelerator LP
13.9.1 MEDX Xelerator LP Company Information
13.9.2 MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Product Offered
13.9.3 MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 MEDX Xelerator LP Main Business Overview
13.9.5 MEDX Xelerator LP Latest Developments
13.10 Cardia Inc
13.10.1 Cardia Inc Company Information
13.10.2 Cardia Inc Percutaneous Left Atrial Appendage Closure Device Product Offered
13.10.3 Cardia Inc Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Cardia Inc Main Business Overview
13.10.5 Cardia Inc Latest Developments
14 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Percutaneous Left Atrial Appendage Closure Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Percutaneous Left Atrial Appendage Closure Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Endocardial LAA Closure Devices
Table 4. Major Players of Epicardial LAA Closure Devices
Table 5. Global Percutaneous Left Atrial Appendage Closure Device Sales by Type (2017-2022) & (K Units)
Table 6. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2017-2022)
Table 7. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Type (2017-2022) & ($ million)
Table 8. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Type (2017-2022)
Table 9. Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Percutaneous Left Atrial Appendage Closure Device Sales by Application (2017-2022) & (K Units)
Table 11. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2017-2022)
Table 12. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Application (2017-2022)
Table 13. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Application (2017-2022)
Table 14. Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Percutaneous Left Atrial Appendage Closure Device Sales by Company (2020-2022) & (K Units)
Table 16. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Company (2020-2022)
Table 17. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Company (2020-2022)
Table 19. Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Percutaneous Left Atrial Appendage Closure Device Producing Area Distribution and Sales Area
Table 21. Players Percutaneous Left Atrial Appendage Closure Device Products Offered
Table 22. Percutaneous Left Atrial Appendage Closure Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Percutaneous Left Atrial Appendage Closure Device Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share Geographic Region (2017-2022)
Table 27. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Percutaneous Left Atrial Appendage Closure Device Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country/Region (2017-2022)
Table 31. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Percutaneous Left Atrial Appendage Closure Device Sales by Country (2017-2022) & (K Units)
Table 34. Americas Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country (2017-2022)
Table 35. Americas Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country (2017-2022)
Table 37. Americas Percutaneous Left Atrial Appendage Closure Device Sales by Type (2017-2022) & (K Units)
Table 38. Americas Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2017-2022)
Table 39. Americas Percutaneous Left Atrial Appendage Closure Device Sales by Application (2017-2022) & (K Units)
Table 40. Americas Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2017-2022)
Table 41. APAC Percutaneous Left Atrial Appendage Closure Device Sales by Region (2017-2022) & (K Units)
Table 42. APAC Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Region (2017-2022)
Table 43. APAC Percutaneous Left Atrial Appendage Closure Device Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Region (2017-2022)
Table 45. APAC Percutaneous Left Atrial Appendage Closure Device Sales by Type (2017-2022) & (K Units)
Table 46. APAC Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2017-2022)
Table 47. APAC Percutaneous Left Atrial Appendage Closure Device Sales by Application (2017-2022) & (K Units)
Table 48. APAC Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2017-2022)
Table 49. Europe Percutaneous Left Atrial Appendage Closure Device Sales by Country (2017-2022) & (K Units)
Table 50. Europe Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country (2017-2022)
Table 51. Europe Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country (2017-2022)
Table 53. Europe Percutaneous Left Atrial Appendage Closure Device Sales by Type (2017-2022) & (K Units)
Table 54. Europe Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2017-2022)
Table 55. Europe Percutaneous Left Atrial Appendage Closure Device Sales by Application (2017-2022) & (K Units)
Table 56. Europe Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Percutaneous Left Atrial Appendage Closure Device
Table 66. Key Market Challenges & Risks of Percutaneous Left Atrial Appendage Closure Device
Table 67. Key Industry Trends of Percutaneous Left Atrial Appendage Closure Device
Table 68. Percutaneous Left Atrial Appendage Closure Device Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Percutaneous Left Atrial Appendage Closure Device Distributors List
Table 71. Percutaneous Left Atrial Appendage Closure Device Customer List
Table 72. Global Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Forecast by Region
Table 74. Global Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share Forecast by Application (2023-2028)
Table 92. Abbott Laboratories Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 94. Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Abbott Laboratories Main Business
Table 96. Abbott Laboratories Latest Developments
Table 97. AtriCure Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 98. AtriCure Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 99. AtriCure Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. AtriCure Main Business
Table 101. AtriCure Latest Developments
Table 102. Boston Scientific Corporation Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 103. Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 104. Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Boston Scientific Corporation Main Business
Table 106. Boston Scientific Corporation Latest Developments
Table 107. Johnson and Johnson Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 109. Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Johnson and Johnson Main Business
Table 111. Johnson and Johnson Latest Developments
Table 112. Lifetech Scientific Corporation Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 113. Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 114. Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Lifetech Scientific Corporation Main Business
Table 116. Lifetech Scientific Corporation Latest Developments
Table 117. Occlutech GmbH Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 118. Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 119. Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Occlutech GmbH Main Business
Table 121. Occlutech GmbH Latest Developments
Table 122. Biosense Webster Inc Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 123. Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 124. Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Biosense Webster Inc Main Business
Table 126. Biosense Webster Inc Latest Developments
Table 127. SentreHeart Inc. Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 128. SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 129. SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. SentreHeart Inc. Main Business
Table 131. SentreHeart Inc. Latest Developments
Table 132. MEDX Xelerator LP Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 133. MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 134. MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. MEDX Xelerator LP Main Business
Table 136. MEDX Xelerator LP Latest Developments
Table 137. Cardia Inc Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 138. Cardia Inc Percutaneous Left Atrial Appendage Closure Device Product Offered
Table 139. Cardia Inc Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Cardia Inc Main Business
Table 141. Cardia Inc Latest Developments
List of Figures
Figure 1. Picture of Percutaneous Left Atrial Appendage Closure Device
Figure 2. Percutaneous Left Atrial Appendage Closure Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Percutaneous Left Atrial Appendage Closure Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Percutaneous Left Atrial Appendage Closure Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Percutaneous Left Atrial Appendage Closure Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Endocardial LAA Closure Devices
Figure 10. Product Picture of Epicardial LAA Closure Devices
Figure 11. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type in 2021
Figure 12. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Type (2017-2022)
Figure 13. Percutaneous Left Atrial Appendage Closure Device Consumed in Hospitals
Figure 14. Global Percutaneous Left Atrial Appendage Closure Device Market: Hospitals (2017-2022) & (K Units)
Figure 15. Percutaneous Left Atrial Appendage Closure Device Consumed in Ambulatory Surgery Centres
Figure 16. Global Percutaneous Left Atrial Appendage Closure Device Market: Ambulatory Surgery Centres (2017-2022) & (K Units)
Figure 17. Percutaneous Left Atrial Appendage Closure Device Consumed in Others
Figure 18. Global Percutaneous Left Atrial Appendage Closure Device Market: Others (2017-2022) & (K Units)
Figure 19. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2017-2022)
Figure 20. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Application in 2021
Figure 21. Percutaneous Left Atrial Appendage Closure Device Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Company in 2021
Figure 23. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Geographic Region in 2021
Figure 25. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Region (2017-2022)
Figure 26. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country/Region in 2021
Figure 27. Americas Percutaneous Left Atrial Appendage Closure Device Sales 2017-2022 (K Units)
Figure 28. Americas Percutaneous Left Atrial Appendage Closure Device Revenue 2017-2022 ($ Millions)
Figure 29. APAC Percutaneous Left Atrial Appendage Closure Device Sales 2017-2022 (K Units)
Figure 30. APAC Percutaneous Left Atrial Appendage Closure Device Revenue 2017-2022 ($ Millions)
Figure 31. Europe Percutaneous Left Atrial Appendage Closure Device Sales 2017-2022 (K Units)
Figure 32. Europe Percutaneous Left Atrial Appendage Closure Device Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue 2017-2022 ($ Millions)
Figure 35. Americas Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country in 2021
Figure 36. Americas Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country in 2021
Figure 37. United States Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Region in 2021
Figure 42. APAC Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Regions in 2021
Figure 43. China Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country in 2021
Figure 50. Europe Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country in 2021
Figure 51. Germany Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country in 2021
Figure 58. Egypt Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Percutaneous Left Atrial Appendage Closure Device in 2021
Figure 64. Manufacturing Process Analysis of Percutaneous Left Atrial Appendage Closure Device
Figure 65. Industry Chain Structure of Percutaneous Left Atrial Appendage Closure Device
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles


Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets